Ophthalmic Drugs Global Market Report 2024

Description

“Ophthalmic Drugs Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ophthalmic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ophthalmic drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The ophthalmic drugs market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Type: Prescription Drugs; Over-The-Counter Drugs
2) By Class: Anti-Allergy; Anti-Inflammatory; Anti-Glaucoma; Other Classes
3) By Disease: Dry Eye; Eye Allergy; Glaucoma; Eye Infection; Retinal Disorders; Uveitis; Other Diseases
4) By Dosage Form: Liquid Ophthalmic Drug Forms; Solid Ophthalmic Drug Forms; Semisolid Ophthalmic Drug Forms; Multicompartment Drug Delivery Systems
5) By Distribution Channel: Hospital Pharmacies; Drug Stores; Online Pharmacies
Companies Mentioned: AbbVie Inc.; Alcon Inc.; Bausch & Lomb Incorporated; F. Hoffmann-La Roche Ltd.; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Ophthalmic drugs comprise pharmaceuticals used to treat various eye-related conditions and vision impairments. These medications are often employed in addressing eye infections.

Two primary categories of ophthalmic drugs exist prescription drugs and over-the-counter (OTC) drugs. Prescription ophthalmic drugs necessitate a licensed doctor's or medical practitioner's prescription for acquisition. They encompass classes such as anti-allergy, anti-inflammatory, anti-glaucoma, and others, catering to conditions such as dry eye, eye allergies, glaucoma, eye infections, retinal disorders, uveitis, among others. These drugs are available in diverse dosage forms, including liquid, solid, semisolid, and multicompartment drug delivery systems. Distribution channels for these medications span hospital pharmacies, drugstores, and online pharmacies.

The ophthalmic drugs market research report is one of a series of new reports from The Business Research Company that provides ophthalmic drugs market statistics, including ophthalmic drugs industry global market size, regional shares, competitors with an ophthalmic drugs market share, detailed ophthalmic drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the ophthalmic drugs industry. The ophthalmic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ophthalmic drugs market size has grown strongly in recent years. It will grow from $36.77 billion in 2023 to $39.82 billion in 2024 at a compound annual growth rate (CAGR) of 8.3%. The growth observed in the historical period can be attributed to several factors, including a rise in the incidence of eye disorders, significant investments in research and development within the field of eye care, shifts in lifestyles impacting eye health, a global increase in cases of diabetes (which often correlates with eye-related complications), and various government initiatives aimed at promoting and enhancing vision care.

The ophthalmic drugs market size is expected to see strong growth in the next few years. It will grow to $53.09 billion in 2028 at a compound annual growth rate (CAGR) of 7.5%. Anticipated growth in the forecasted period is expected to stem from biopharmaceutical advancements, a rising prevalence of myopia, the expanding elderly population, personalized medicine strategies, and supportive regulatory frameworks targeting rare diseases. Significant trends projected for this period encompass the development of biologics and gene therapies, an increased emphasis on therapeutics for dry eye conditions, advancements in treating glaucoma, the emergence of combination therapies, and a concentrated focus on addressing age-related macular degeneration (AMD).

The prevalence of ophthalmic disorders is expected to drive significant growth within the ophthalmic drug market. These disorders encompass various ailments affecting the eye, leading to vision impairment and other eye-related issues. Ophthalmic drugs, formulated to address such conditions, witness heightened demand as these disorders become more prevalent. As reported by the University College London in 2020, an estimated 596 million individuals globally suffered from untreated "distance vision impairment," including conditions such as cataracts, glaucoma, or eye problems associated with diabetes. Projections suggest a substantial surge to 895 million individuals by 2050, with 61 million facing blindness. This rise in ophthalmic disorders fuels the expansion of the ophthalmic drug market.

The upsurge in healthcare spending is anticipated to bolster the growth of the ophthalmic drugs market. Healthcare expenditure, comprising expenses related to medical care, including medications for eye-related conditions, significantly influences the growth of the ophthalmic drugs sector within the overall healthcare budget. Notably, the Canadian Institute for Health Information forecasted a 0.8% increase in total health spending in Canada from $328 billion in 2021 to $331 billion in 2022. This escalation in healthcare expenditure underscores the growth trajectory within the ophthalmic drugs market.

Product innovation stands as a prominent trend shaping the ophthalmic drug market. Leading companies in this sector concentrate on novel solutions to fortify their market positions. An example is Sun Pharmaceutical Canada Inc.'s launch of CEQUA (cyclosporine ophthalmic solution 0.09% w/v) in January 2022. CEQUA utilizes nanomicellar (NCELL) technology, enhancing drug delivery to ocular tissues by improving cyclosporine's bioavailability and stability, primarily targeting dry eye disease.

Companies focus on developing preservative-free drugs, such as preservative-free latanoprost, offering efficacious treatment options. Thea Pharma introduced Iyuzeh (latanoprost ophthalmic solution) 0.005% in September 2023, the first preservative-free latanoprost approved by the FDA for primary open-angle glaucoma (POAG) and ocular hypertension (OHT) in the US. This launch responds to the needs of over 60 million global individuals affected by glaucoma, presenting an effective and preservative-free treatment option within the ophthalmic drugs market.

In November 2022, Alcon Inc., a Switzerland-based leader in eye care, completed the acquisition of Aerie Pharmaceuticals, Inc., a US-based research and development company specializing in ophthalmic disease treatments. The undisclosed deal granted Alcon access to Aerie's existing commercial drug Rhopressa and the developmental drug Rocklatan. This strategic move expands Alcon's pharmaceutical portfolio while leveraging Aerie's research and development capabilities. Alcon aims to harness Aerie's pipeline of ophthalmic drugs, potentially transitioning them into commercially viable treatments. Aerie Pharmaceuticals focuses on innovating drugs for various eye conditions, including dry eye and glaucoma, aligning with Alcon's commitment to advancing eye care solutions.

Major companies operating in the ophthalmic drugs market report are AbbVie Inc., Alcon Inc., Bausch & Lomb Incorporated, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Nicox S.A., Coherus Biosciences Inc., Johnson & Johnson, Otsuka Pharmaceutical Co. Ltd., Viatris Inc., Mitotech SA, Akorn Incorporated, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Bayer AG, Senju Pharmaceutical Co. Ltd., Aerie Pharmaceuticals Inc., Kala Pharmaceuticals Inc., Aurobindo Pharma Ltd., Eyevance Pharmaceuticals, Acucela Inc., Dompe Farmaceutici S.p.A., Xbrane Biopharma AB, Laboratoires Thea

North America was the largest region in the ophthalmic drugs market in 2023. The regions covered in the ophthalmic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the ophthalmic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The ophthalmic drugs market consists of ophthalmic sales of anti-angiogenic drugs, anti-vascular endothelial growth factor drugs, anti-uveitis drugs, and prostaglandin analogs. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r11970

1. Executive Summary

2. Ophthalmic Drugs Market Characteristics

3. Ophthalmic Drugs Market Trends And Strategies

4. Ophthalmic Drugs Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Ophthalmic Drugs Market Size and Growth

5.1. Global Ophthalmic Drugs Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Ophthalmic Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Ophthalmic Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Ophthalmic Drugs Market Segmentation

6.1. Global Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Prescription Drugs
Over-The-Counter Drugs
6.2. Global Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Anti-Allergy
Anti-Inflammatory
Anti-Glaucoma
Other Classes
6.3. Global Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Dry Eye
Eye Allergy
Glaucoma
Eye Infection
Retinal Disorders
Uveitis
Other Diseases
6.4. Global Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Liquid Ophthalmic Drug Forms
Solid Ophthalmic Drug Forms
Semisolid Ophthalmic Drug Forms
Multicompartment Drug Delivery Systems
6.5. Global Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Drug Stores
Online Pharmacies

7. Ophthalmic Drugs Market Regional And Country Analysis

7.1. Global Ophthalmic Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Ophthalmic Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Ophthalmic Drugs Market

8.1. Asia-Pacific Ophthalmic Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Ophthalmic Drugs Market

9.1. China Ophthalmic Drugs Market Overview
9.2. China Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Ophthalmic Drugs Market

10.1. India Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Ophthalmic Drugs Market

11.1. Japan Ophthalmic Drugs Market Overview
11.2. Japan Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Ophthalmic Drugs Market

12.1. Australia Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Ophthalmic Drugs Market

13.1. Indonesia Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Ophthalmic Drugs Market

14.1. South Korea Ophthalmic Drugs Market Overview
14.2. South Korea Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Ophthalmic Drugs Market

15.1. Western Europe Ophthalmic Drugs Market Overview
15.2. Western Europe Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Ophthalmic Drugs Market

16.1. UK Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Ophthalmic Drugs Market

17.1. Germany Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Ophthalmic Drugs Market

18.1. France Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Ophthalmic Drugs Market

19.1. Italy Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Ophthalmic Drugs Market

20.1. Spain Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Ophthalmic Drugs Market

21.1. Eastern Europe Ophthalmic Drugs Market Overview
21.2. Eastern Europe Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Ophthalmic Drugs Market

22.1. Russia Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Ophthalmic Drugs Market

23.1. North America Ophthalmic Drugs Market Overview
23.2. North America Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Ophthalmic Drugs Market

24.1. USA Ophthalmic Drugs Market Overview
24.2. USA Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Ophthalmic Drugs Market

25.1. Canada Ophthalmic Drugs Market Overview
25.2. Canada Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Ophthalmic Drugs Market

26.1. South America Ophthalmic Drugs Market Overview
26.2. South America Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Ophthalmic Drugs Market

27.1. Brazil Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Ophthalmic Drugs Market

28.1. Middle East Ophthalmic Drugs Market Overview
28.2. Middle East Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Ophthalmic Drugs Market

29.1. Africa Ophthalmic Drugs Market Overview
29.2. Africa Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Ophthalmic Drugs Market Competitive Landscape And Company Profiles

30.1. Ophthalmic Drugs Market Competitive Landscape
30.2. Ophthalmic Drugs Market Company Profiles
- 30.2.1. AbbVie Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Alcon Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Bausch & Lomb Incorporated
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. F. Hoffmann-La Roche Ltd.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Novartis AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Ophthalmic Drugs Market Competitive Benchmarking

32. Global Ophthalmic Drugs Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Ophthalmic Drugs Market

34. Ophthalmic Drugs Market Future Outlook and Potential Analysis

34.1 Ophthalmic Drugs Market In 2028 - Countries Offering Most New Opportunities
34.2 Ophthalmic Drugs Market In 2028 - Segments Offering Most New Opportunities
34.3 Ophthalmic Drugs Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer